Tolerability and efficacy of dorzolamide versus acetazolamide added to timolol

Journal of Ocular Pharmacology and Therapeutics

Volumn 18, Issue 3, 2002, Pages 211-220

  Stewart, William C ^a,b   Halper, Lee K ^c   Johnson Pratt, Lisa ^c   Polis, Adam ^c   Hartenbaum, David ^c  

^a University of South Carolina   (United States)

^b UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; DORZOLAMIDE; EYE DROPS; TIMOLOL MALEATE; CARBONATE DEHYDRATASE INHIBITOR; SULFONAMIDE; THIOPHENE DERIVATIVE; TIMOLOL;

ABDOMINAL PAIN; ADULT; AGED; ANOREXIA; ARTICLE; ASTHENIA; BLOOD PRESSURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSPEPSIA; EYE IRRITATION; FATIGUE; FEMALE; HEADACHE; HEART RATE; HUMAN; HYPERGLYCEMIA; HYPOKALEMIA; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTICENTER STUDY; NAUSEA; OPEN ANGLE GLAUCOMA; PARESTHESIA; PUNCTATE KERATITIS; RANDOMIZED CONTROLLED TRIAL; TASTE DISORDER; UPPER RESPIRATORY TRACT INFECTION; COMPARATIVE STUDY; DRUG COMBINATION; DRUG EFFECT; MIDDLE AGED; ORAL DRUG ADMINISTRATION; TOPICAL DRUG ADMINISTRATION;

ACETAZOLAMIDE; ADMINISTRATION, ORAL; ADMINISTRATION, TOPICAL; ADULT; AGED; AGED, 80 AND OVER; CARBONIC ANHYDRASE INHIBITORS; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; DRUG THERAPY, COMBINATION; FEMALE; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; OCULAR HYPERTENSION; SULFONAMIDES; THIOPHENES; TIMOLOL;

EID: 0035990094     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/108076802760116133     Document Type: Article

References (17)

1. A comparison of the efficacy and tolerability of dorzolamide and acetazolamide as adjunctive therapy to timolol
2. The use of dorzolamide and pilocarpine as adjunctive therapy to timolol in patients with elevated intraocular pressure
3. Carbonic anhydrase inhibitor side effects: Serum chemical analysis
4. Dose response and duration of action of dorzolamide, a topical carbonic anhydrase inhibitor
5. MK-507 versus sezolamide: Comparative efficacy of two topically active carbonic anhydrase inhibitors
6. Four-week safety and efficacy study of dorzolamide, a novel, active topical carbonic anhydrase inhibitor
7. A six-week dose-response study of the ocular hypotensive effect of dorzolamide with a one-year extension
8. A double-masked, randomized 1-year study comparing dorzolamide (Trusopt), timolol, and betaxolol
9. The efficacy and safety of dorzolamide as adjunctive therapy to timolol maleate gellan solution in patients with elevated intraocular pressure
10. Two-year safety study of dorzolamide as monotherapy and with timolol and pilocarpine
11. A double-masked, randomized, 1-year study comparing the corneal effects of dorzolamide, timolol, and betaxolol
12. New and current drug therapy for glaucoma
13. Propranolol vs acetazolamide. A long-term double-masked study of the effect on intraocular pressure and blood pressure